Parkman Healthcare Partners LLC
CIK 1777015 · View on SEC EDGAR ↗
- Portfolio value
- $976.8M
- Positions
- 77
- As of
- June 30, 2026
#2,495 of 9,443 by 13F value · top 26.4%
Portfolio value QoQ: +0.7% 13F does not disclose cash
- Top 10 holdings weight
- 33.49%
- Top 25 holdings weight
- 63.56%
- Positions above 1%
- 40
- Effective number of positions
- 46.7
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 28.35% Est. buys $275,892,837 · sells $361,801,571
Median holding: 3.0 quarters Tracked Q4 2024–Q2 2026 · 41.4% still held
- New positions
- 18
- Increased
- 27
- Decreased
- 30
- Closed
- 30
Put-notional exposure: 0.3% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Annualized: +20.8% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 96.9% · Options excluded: 1.1%
Sector breakdown
Healthcare
98.8%
Other/Unmapped
1.2%
Full portfolio 77 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences, Inc. - Common Stock | $44,169,550 | 4.52% | 800,173 | $20,288,446 | Up ×1 | ||
| LLY Eli Lilly and Company Common Stock | $41,980,050 | 4.30% | 35,000 | $10,141,292 | Up ×1 | ||
| CVS CVS Health Corporation Common Stock | $40,530,779 | 4.15% | 391,791 | $12,714,462 | Up ×1 | ||
| DXCM DexCom, Inc. - Common Stock | $36,016,557 | 3.69% | 534,767 | $-7,304,265 | Down ×1 | ||
| PTCT PTC Therapeutics, Inc. - Common Stock | $35,539,315 | 3.64% | 435,691 | $6,150,486 | Up ×2 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $28,340,971 | 2.90% | 919,266 | $2,263,853 | Down ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $26,065,426 | 2.67% | 485,661 | $14,878,543 | Up ×2 | ||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $25,306,071 | 2.59% | 1,377,576 | $14,392,843 | Up ×1 | ||
| AGIO Agios Pharmaceuticals, Inc. - Common Stock | $24,828,297 | 2.54% | 669,046 | $11,177,046 | Up ×2 | ||
| INBX Inhibrx Biosciences, Inc. - Common Stock | $24,346,013 | 2.49% | 256,950 | Up ×1 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $23,985,796 | 2.46% | 397,379 | $-4,916,789 | Down ×1 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $23,444,973 | 2.40% | 577,036 | $13,275,891 | Up ×1 | ||
| UNH UnitedHealth Group Incorporated Common Stock (DE) | $23,242,445 | 2.38% | 55,921 | ||||
| SYK Stryker Corporation Common Stock | $21,400,619 | 2.19% | 67,973 | $-29,455,584 | Down ×1 | ||
| IQV IQVIA Holdings, Inc. Common Stock | $20,444,801 | 2.09% | 105,811 | $5,658,642 | Up ×3 | ||
| ZBH Zimmer Biomet Holdings, Inc. Common Stock | $20,020,832 | 2.05% | 232,557 | $-4,352,512 | Down ×1 | ||
| PODD Insulet Corporation - Common Stock | $20,002,301 | 2.05% | 131,378 | $-12,850,459 | Down ×1 | ||
| ASMB Assembly Biosciences, Inc. - Common Stock | $19,818,054 | 2.03% | 721,181 | $8,406,505 | Up ×2 | ||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $19,176,816 | 1.96% | 877,256 | $-1,882,481 | Down ×1 | ||
| EYPT EyePoint, Inc. - Common Stock | $18,420,731 | 1.89% | 1,288,163 | $957,359 | Down ×1 | ||
| THC Tenet Healthcare Corporation Common Stock | $18,199,142 | 1.86% | 97,280 | $8,740,431 | Up ×1 | ||
| LIVN LivaNova PLC - Ordinary Shares | $17,311,800 | 1.77% | 210,529 | $-8,364,215 | Down ×2 | ||
| ANIP ANI Pharmaceuticals, Inc. - Common Stock | $16,796,641 | 1.72% | 202,907 | $-4,779,577 | Down ×1 | ||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $16,242,790 | 1.66% | 1,624,279 | $-18,312 | Down ×1 | ||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $15,253,792 | 1.56% | 50,672 | $6,348,095 | Up ×1 | ||
| INDV Indivior Pharmaceuticals, Inc. - Common Stock | $14,945,957 | 1.53% | 364,269 | Up ×1 | |||
| NVST Envista Holdings Corporation Common Stock | $14,595,687 | 1.49% | 553,916 | $-3,459,964 | Down ×1 | ||
| DRUG Bright Minds Biosciences Inc. - common stock | $14,394,721 | 1.47% | 205,053 | $11,468,770 | Up ×1 | ||
| XERS Xeris Biopharma Holdings, Inc. - Common Stock | $14,316,358 | 1.47% | 1,807,621 | $4,333,027 | Up ×2 | ||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $14,161,039 | 1.45% | 766,290 | Up ×1 | |||
| FDMT 4D Molecular Therapeutics, Inc. - Common Stock | $12,610,847 | 1.29% | 948,184 | $7,745,655 | Up ×3 | ||
| IMNM Immunome, Inc. - Common Stock | $12,591,140 | 1.29% | 594,202 | $3,766,879 | Up ×2 | ||
| STOK Stoke Therapeutics, Inc. - Common Stock | $11,630,095 | 1.19% | 355,443 | $673,036 | Up ×1 | ||
| WAT Waters Corporation Common Stock | $11,328,458 | 1.16% | 30,206 | $3,452,541 | Up ×1 | ||
| ANRO Alto Neuroscience, Inc. Common Stock | $11,322,234 | 1.16% | 429,035 | Up ×1 | |||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $10,772,102 | 1.10% | 113,188 | Up ×1 | |||
| ADPT Adaptive Biotechnologies Corporation - Common Stock | $10,445,807 | 1.07% | 486,984 | $2,786,615 | Down ×1 | ||
| ABSI Absci Corporation - Common Stock | $10,365,795 | 1.06% | 894,374 | $4,771,377 | Down ×1 | ||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $10,261,951 | 1.05% | 380,354 | $-35,960 | Up ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $9,805,226 | 1.00% | 253,365 | $5,951,376 | Up ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $9,588,310 | 0.98% | 208,170 | $6,206,443 | Up ×1 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $9,441,000 | 0.97% | 150,000 | Up ×1 | |||
| AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | $9,367,999 | 0.96% | 541,190 | $5,629,652 | Up ×1 | ||
| IRTC iRhythm Holdings, Inc. - Common Stock | $8,001,410 | 0.82% | 67,267 | $3,265,857 | Up ×1 | ||
| CYRX CryoPort, Inc. - Common Stock | $7,980,687 | 0.82% | 508,324 | Up ×1 | |||
| BSX Boston Scientific Corporation Common Stock | $7,702,929 | 0.79% | 180,481 | $-20,457,263 | Down ×2 | ||
| CLYM Climb Bio, Inc. - Common Stock | $7,347,831 | 0.75% | 563,484 | ||||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $7,162,125 | 0.73% | 398,782 | $-1,476,141 | Down ×1 | ||
| UPB Upstream Bio, Inc. - Common Stock | $6,471,909 | 0.66% | 935,247 | $-609,138 | Up ×1 | ||
| RMD ResMed Inc. Common Stock | $6,427,727 | 0.66% | 32,983 | ||||
| URGN UroGen Pharma Ltd. - Ordinary Shares | $6,405,555 | 0.66% | 174,064 | $1,461,055 | Down ×1 | ||
| ALGN Align Technology, Inc. - Common Stock | $6,234,180 | 0.64% | 36,963 | $2,594,207 | Up ×1 | ||
| CARL Carlsmed, Inc. - Common Stock | $6,200,161 | 0.63% | 597,318 | $1,483,998 | Up ×1 | ||
| AVAH Aveanna Healthcare Holdings Inc. - Common Stock | $6,122,845 | 0.63% | 714,451 | Up ×1 | |||
| CDNA CareDx, Inc. - Common Stock | $5,768,885 | 0.59% | 202,417 | $710,563 | Down ×1 | ||
| SIBN SI-BONE, Inc. - Common Stock | $5,364,156 | 0.55% | 328,686 | $646,182 | Down ×3 | ||
| VIR Vir Biotechnology, Inc. - Common Stock | $4,843,093 | 0.50% | 475,279 | $363,093 | Down ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $4,739,091 | 0.49% | 258,684 | $-1,841,347 | Down ×1 | ||
| SI Shoulder Innovations, Inc. Common Stock | $4,587,579 | 0.47% | 226,212 | Up ×1 | |||
| WAY Waystar Holding Corp. - Common Stock | $4,187,833 | 0.43% | 203,986 | $-6,494,295 | Down ×1 | ||
| ATEC Alphatec Holdings, Inc. - Common Stock | $3,892,007 | 0.40% | 449,943 | $-5,070,534 | Down ×1 | ||
| ANNX Annexon, Inc. - common stock | $3,660,276 | 0.37% | 641,029 | $-73,756 | Down ×1 | ||
| CSTL Castle Biosciences, Inc. - Common stock | $3,453,265 | 0.35% | 144,791 | $356,282 | Up ×1 | ||
| Unknown issuer (CUSIP: 60365F109) | $3,385,368 | 0.35% | 226,446 | $-1,349,106 | Down ×1 | ||
| EIKN Eikon Therapeutics, Inc. - Common Stock | $3,341,492 | 0.34% | 256,053 | Up ×1 | |||
| VTRS Viatris Inc. - Common Stock | $3,176,000 | 0.33% | 200,000 | Up ×1 | |||
| Unknown issuer (CUSIP: 384747951) | $3,140,420 | 0.32% | 46,000 | Put option | Up ×1 | ||
| AORT Artivion, Inc. Common Stock | $3,121,982 | 0.32% | 138,940 | $-6,106,771 | Down ×1 | ||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $2,447,700 | 0.25% | 10,000 | Up ×1 | |||
| OPRX OptimizeRx Corporation - Common Stock | $2,003,985 | 0.21% | 350,347 | $-2,576,452 | Down ×1 | ||
| NSPR InspireMD Inc. - Common Stock | $1,691,804 | 0.17% | 2,416,518 | $-2,247,120 | |||
| Unknown issuer (CUSIP: 423494103) | $1,652,850 | 0.17% | 45,000 | Up ×1 | |||
| LUNG Pulmonx Corporation - Common Stock | $840,533 | 0.09% | 646,564 | $-134,237 | Down ×1 | ||
| SPRY ARS Pharmaceuticals, Inc. - Common Stock | $822,627 | 0.08% | 102,700 | Up ×1 | |||
| EDAP EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share | $802,030 | 0.08% | 154,832 | $226,055 | |||
| OVID Ovid Therapeutics Inc. - Common Stock | $532,477 | 0.05% | 197,947 | $70,262 | Down ×1 | ||
| ENTX Entera Bio Ltd. - Ordinary Shares | $485,860 | 0.05% | 274,497 | $165,436 | Down ×1 | ||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| INBX | $24,346,013 | 256,950 | 2.49% |
| UNH | $23,242,445 | 55,921 | 2.38% |
| INDV | $14,945,957 | 364,269 | 1.53% |
| AVTX | $14,161,039 | 766,290 | 1.45% |
| ANRO | $11,322,234 | 429,035 | 1.16% |
| ORKA | $10,772,102 | 113,188 | 1.10% |
| TARS | $9,441,000 | 150,000 | 0.97% |
| CYRX | $7,980,687 | 508,324 | 0.82% |
| CLYM | $7,347,831 | 563,484 | 0.75% |
| RMD | $6,427,727 | 32,983 | 0.66% |
| AVAH | $6,122,845 | 714,451 | 0.63% |
| SI | $4,587,579 | 226,212 | 0.47% |
| EIKN | $3,341,492 | 256,053 | 0.34% |
| VTRS | $3,176,000 | 200,000 | 0.33% |
| Unknown issuer (CUSIP: 384747951) | $3,140,420 | 46,000 | 0.32% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| SYK | Trimmed | -87K | -$29.5M |
| BSX | Trimmed | -268K | -$20.5M |
| MBX | Bought more | +136 | +$20.3M |
| GPCR | Bought more | +254K | +$14.9M |
| VRDN | Bought more | +820K | +$14.4M |
| EWTX | Bought more | +254K | +$13.3M |
| PODD | Trimmed | -25K | -$12.9M |
| CVS | Bought more | +4K | +$12.7M |
| DRUG | Bought more | +165K | +$11.5M |
| AGIO | Bought more | +266K | +$11.2M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| QQQ | Dec. 31, 2025 | 80,000 | $48,029,600 | |
| KALV | June 30, 2026 | 1,835,506 | $36,948,736 | No longer tracked |
| BDX | June 30, 2025 | 120,283 | $27,552,024 | 39.4% |
| UNH | June 30, 2025 | 50,213 | $26,299,059 | 24.2% |
| MASI | March 31, 2026 | 200,000 | $26,012,000 | No longer tracked |
| TERN | March 31, 2026 | 620,877 | $25,083,431 | No longer tracked |
| QGENXXXX | March 31, 2026 | 494,351 | $22,230,964 | No longer tracked |
| FOLD | March 31, 2026 | 1,487,283 | $21,178,910 | No longer tracked |
| ITCI | March 31, 2025 | 243,123 | $20,305,633 | No longer tracked |
| QGEN | June 30, 2026 | 500,000 | $20,020,000 | 12.2% |
| ABT | March 31, 2025 | 176,994 | $20,019,791 | -13.8% |
| VRNA | Sept. 30, 2025 | 197,898 | $18,717,193 | No longer tracked |
| ABBV | June 30, 2026 | 75,000 | $16,311,750 | 4.8% |
| MTD | March 31, 2026 | 10,988 | $15,319,360 | 10.4% |
| RVTY | Sept. 30, 2025 | 157,196 | $15,203,997 | 40.1% |
| GILD | Sept. 30, 2025 | 131,675 | $14,598,807 | 30.5% |
| A | March 31, 2026 | 100,000 | $13,607,000 | 37.2% |
| ILMN | June 30, 2026 | 110,370 | $13,604,206 | 19.4% |
| DHR | March 31, 2026 | 58,889 | $13,480,870 | 12.9% |
| EW | June 30, 2026 | 167,155 | $13,385,772 | -1.2% |
| NBIX | June 30, 2026 | 99,069 | $13,051,350 | -8.6% |
| KNSA | June 30, 2026 | 259,184 | $12,479,710 | 22.0% |
| MCK | June 30, 2026 | 12,676 | $10,969,303 | 13.4% |
| UNH | March 31, 2026 | 31,875 | $10,522,256 | 43.1% |
| UTHR | Dec. 31, 2025 | 22,000 | $9,222,620 | 8.0% |
| NUVL | June 30, 2026 | 88,078 | $9,023,591 | No longer tracked |
| AXGN | June 30, 2026 | 268,160 | $8,884,141 | 0.7% |
| MRUS | Sept. 30, 2025 | 162,980 | $8,572,748 | No longer tracked |
| INCY | Dec. 31, 2025 | 100,442 | $8,518,486 | 29.1% |
| IDXX | June 30, 2026 | 15,000 | $8,428,350 | 3.8% |
| ANIP | Sept. 30, 2025 | 128,478 | $8,383,190 | -15.2% |
| ACLX | March 31, 2026 | 128,111 | $8,352,837 | No longer tracked |
| REPL | Sept. 30, 2025 | 896,710 | $8,330,436 | 249.0% |
| ASND | Dec. 31, 2025 | 40,343 | $8,020,592 | 20.9% |
| LLY | Dec. 31, 2025 | 10,000 | $7,630,000 | 16.3% |
| DGX | Sept. 30, 2025 | 40,997 | $7,364,291 | 26.2% |
| DOCS | March 31, 2026 | 162,276 | $7,185,581 | 9.5% |
| BMRN | Dec. 31, 2025 | 125,949 | $6,821,398 | 13.8% |
| APGE | June 30, 2026 | 77,686 | $6,538,831 | 1.6% |
| COO | June 30, 2026 | 89,883 | $6,426,635 | 5.7% |
| OM | Dec. 31, 2025 | 454,512 | $6,417,709 | 17.3% |
| BIIB | March 31, 2026 | 35,425 | $6,234,446 | 17.6% |
| DAWN | March 31, 2026 | 645,544 | $6,016,470 | No longer tracked |
| ALKS | Sept. 30, 2025 | 200,000 | $5,722,000 | 60.2% |
| TNGX | June 30, 2026 | 266,127 | $5,567,377 | -23.1% |
| TMDX | March 31, 2026 | 45,174 | $5,495,417 | -7.3% |
| SDGR | March 31, 2026 | 298,939 | $5,345,029 | 74.1% |
| VERA | March 31, 2026 | 100,564 | $5,092,561 | -21.3% |
| RMD | June 30, 2025 | 22,622 | $5,063,935 | -10.9% |
| BCYC | March 31, 2025 | 352,481 | $4,934,734 | -48.6% |
| RARE | June 30, 2026 | 235,000 | $4,923,250 | -21.8% |
| PHLT | Sept. 30, 2025 | 1,214,272 | $4,857,088 | No longer tracked |
| ABVX | Dec. 31, 2025 | 55,197 | $4,686,225 | -11.4% |
| JAZZ | March 31, 2025 | 37,751 | $4,649,036 | 101.7% |
| SUPN | June 30, 2026 | 85,062 | $4,396,855 | 2.0% |
| TEVA | March 31, 2025 | 196,805 | $4,337,582 | 141.8% |
| PGEN | March 31, 2026 | 1,002,826 | $4,191,813 | 88.6% |
| CAI | June 30, 2026 | 229,912 | $4,110,827 | 40.0% |
| SYRE | March 31, 2026 | 124,485 | $4,078,129 | 116.5% |
| CVRX | June 30, 2026 | 429,507 | $4,063,136 | -43.1% |
| NARI | March 31, 2025 | 77,223 | $3,942,234 | No longer tracked |
| GH | June 30, 2025 | 89,329 | $3,805,415 | 219.6% |
| ETON | March 31, 2025 | 276,890 | $3,688,175 | 369.5% |
| MNKD | March 31, 2026 | 640,356 | $3,630,819 | 75.7% |
| PCVX | June 30, 2025 | 93,431 | $3,527,955 | 91.6% |
| ICLR | March 31, 2025 | 15,874 | $3,328,937 | -1.3% |
| TVTX | March 31, 2026 | 86,297 | $3,297,408 | 118.7% |
| WGS | June 30, 2026 | 50,778 | $3,260,963 | 18.5% |
| VCYT | June 30, 2026 | 101,237 | $3,260,844 | -29.5% |
| STRO | March 31, 2025 | 1,727,925 | $3,179,382 | 3249.2% |
| CERT | March 31, 2026 | 348,750 | $3,072,488 | 50.7% |
| CMPS | June 30, 2026 | 554,411 | $3,065,893 | -2.4% |
| MLTX | March 31, 2025 | 54,294 | $2,940,020 | -59.4% |
| INSM | June 30, 2025 | 37,901 | $2,891,467 | 24.6% |
| DVAX | Dec. 31, 2025 | 271,306 | $2,694,069 | No longer tracked |
| NRIX | Sept. 30, 2025 | 228,271 | $2,600,007 | 193.1% |
| TVRD | Dec. 31, 2025 | 65,000 | $2,533,050 | -56.9% |
| BFLY | March 31, 2025 | 750,000 | $2,340,000 | 306.3% |
| PTGX | March 31, 2026 | 25,973 | $2,268,482 | 44.1% |
| SLDB | June 30, 2026 | 308,844 | $2,223,677 | -5.7% |
| KROS | June 30, 2025 | 217,753 | $2,218,903 | -18.1% |
| BFLY | June 30, 2026 | 544,477 | $2,199,687 | 10.0% |
| NAMS | June 30, 2025 | 100,955 | $2,066,549 | 54.6% |
| ARVN | March 31, 2025 | 106,871 | $2,048,717 | 30.1% |
| LFST | March 31, 2025 | 277,471 | $2,044,961 | 89.2% |
| OSCR | March 31, 2025 | 125,000 | $1,680,000 | 135.1% |
| QDEL | June 30, 2026 | 101,764 | $1,671,983 | -17.8% |
| ICAD | June 30, 2025 | 781,670 | $1,610,240 | No longer tracked |
| RXST | June 30, 2026 | 249,989 | $1,539,932 | 25.7% |
| MRVI | June 30, 2025 | 660,000 | $1,458,600 | 246.7% |
| ACHC | March 31, 2026 | 100,000 | $1,419,000 | 14.5% |
| INSP | March 31, 2026 | 15,000 | $1,383,450 | 17.7% |
| QTRX | June 30, 2026 | 341,453 | $1,201,915 | -29.3% |
| ARDX | Sept. 30, 2025 | 301,086 | $1,180,257 | -28.1% |
| SENS | March 31, 2026 | 206,793 | $1,141,497 | 39.8% |
| SLN | June 30, 2025 | 401,746 | $1,132,924 | 128.6% |
| ORIC | June 30, 2025 | 203,006 | $1,132,773 | 38.3% |
| PLSE | June 30, 2026 | 50,125 | $1,082,199 | 72.3% |
| CRNX | March 31, 2026 | 22,852 | $1,063,761 | 133.3% |
| RPID | March 31, 2026 | 354,465 | $1,027,949 | -26.0% |
| MAZE | June 30, 2026 | 31,844 | $950,543 | -2.6% |
| RVPH | March 31, 2025 | 514,273 | $930,834 | No longer tracked |
| THRD | March 31, 2025 | 86,707 | $892,215 | No longer tracked |
| MASS | Dec. 31, 2025 | 100,368 | $879,224 | 97.5% |
| MDLN | March 31, 2026 | 20,558 | $863,436 | -25.9% |
| CBLL | March 31, 2025 | 32,002 | $828,212 | 24.6% |
| ATYR | Sept. 30, 2025 | 150,000 | $760,500 | -27.9% |
| ADMA | June 30, 2026 | 82,443 | $742,811 | 17.2% |
| CLYM | March 31, 2025 | 290,491 | $522,884 | 1306.5% |
| RLAY | June 30, 2025 | 188,052 | $492,696 | 479.6% |
| TMCI | March 31, 2026 | 199,393 | $488,513 | 235.4% |
| VYNE | June 30, 2025 | 217,978 | $344,405 | No longer tracked |
| ARAY | June 30, 2026 | 884,578 | $343,305 | 17.6% |
| IRWD | June 30, 2025 | 205,086 | $301,476 | 490.3% |